Takasago Tekko K.K. (TYO:5458)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,831	2,942	2,669	2,462	2,582	2,237
Market Cap Growth	10.24%	10.24%	8.41%	-4.65%	15.43%	33.75%
Enterprise Value	1,468	1,538	1,018	955	726	1,551
Last Close Price	943.00	980.00	853.48	756.95	760.84	633.50
PE Ratio	8.50	8.84	11.41	4.71	3.99	16.69
PS Ratio	0.23	0.24	0.22	0.20	0.24	0.26
PB Ratio	0.60	0.62	0.61	0.57	0.66	0.69
P/TBV Ratio	0.60	0.63	0.61	0.57	0.67	0.70
P/FCF Ratio	-	-	4.01	-	3.02	8.25
P/OCF Ratio	72.59	75.44	2.93	-	2.74	5.87
EV/Sales Ratio	0.12	0.13	0.08	0.08	0.07	0.18
EV/EBITDA Ratio	2.20	2.31	1.73	0.92	0.66	4.02
EV/EBIT Ratio	2.86	3.00	2.60	1.23	0.91	25.42
EV/FCF Ratio	-7.02	-	1.53	-	0.85	5.72
Debt / Equity Ratio	-	-	-	-	-	0.11
Debt / EBITDA Ratio	-	-	-	-	-	0.88
Debt / FCF Ratio	-	-	-	-	-	1.25
Asset Turnover	1.29	1.29	1.32	1.41	1.37	1.19
Inventory Turnover	3.98	3.98	4.15	4.31	4.99	5.11
Quick Ratio	1.34	1.34	1.27	1.26	1.20	1.29
Current Ratio	2.18	2.18	1.90	2.01	1.84	1.77
Return on Equity (ROE)	7.29%	7.29%	5.37%	12.74%	18.13%	4.21%
Return on Assets (ROA)	3.43%	3.43%	2.64%	5.60%	6.31%	0.52%
Return on Capital (ROIC)	7.01%	7.01%	5.61%	11.82%	13.34%	1.09%
Return on Capital Employed (ROCE)	9.00%	9.00%	7.10%	14.60%	16.40%	1.40%
Earnings Yield	11.76%	11.32%	8.77%	21.24%	25.06%	5.99%
FCF Yield	-7.38%	-7.10%	24.95%	-21.08%	33.11%	12.12%
Dividend Yield	4.24%	4.08%	4.10%	4.62%	4.60%	1.58%
Payout Ratio	31.53%	31.53%	44.87%	20.08%	4.64%	22.39%
Total Shareholder Return	4.27%	4.08%	4.10%	4.62%	4.60%	1.58%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.